183 related articles for article (PubMed ID: 35993417)
1. Is there any additional benefit of
Şahin M; Akgun E; Sirolu S; Can G; Sayman HB; Oner Dincbas F
Br J Radiol; 2022 Oct; 95(1139):20220049. PubMed ID: 35993417
[TBL] [Abstract][Full Text] [Related]
2. Gross tumor volume delineation in primary prostate cancer on
Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
4. Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma.
Navarria P; Reggiori G; Pessina F; Ascolese AM; Tomatis S; Mancosu P; Lobefalo F; Clerici E; Lopci E; Bizzi A; Grimaldi M; Chiti A; Simonelli M; Santoro A; Bello L; Scorsetti M
Radiother Oncol; 2014 Sep; 112(3):425-9. PubMed ID: 25308182
[TBL] [Abstract][Full Text] [Related]
5. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
6. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
7.
Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K
Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347
[TBL] [Abstract][Full Text] [Related]
8. A fully automatic approach for multimodal PET and MR image segmentation in gamma knife treatment planning.
Rundo L; Stefano A; Militello C; Russo G; Sabini MG; D'Arrigo C; Marletta F; Ippolito M; Mauri G; Vitabile S; Gilardi MC
Comput Methods Programs Biomed; 2017 Jun; 144():77-96. PubMed ID: 28495008
[TBL] [Abstract][Full Text] [Related]
9. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
10. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results.
Guerra L; Meregalli S; Zorz A; Niespolo R; De Ponti E; Elisei F; Morzenti S; Brenna S; Crespi A; Gardani G; Messa C
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):702-10. PubMed ID: 24177810
[TBL] [Abstract][Full Text] [Related]
12. FET-PET for malignant glioma treatment planning.
Niyazi M; Geisler J; Siefert A; Schwarz SB; Ganswindt U; Garny S; Schnell O; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; la Fougère C; Belka C
Radiother Oncol; 2011 Apr; 99(1):44-8. PubMed ID: 21458093
[TBL] [Abstract][Full Text] [Related]
13. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
[TBL] [Abstract][Full Text] [Related]
14. Comparison of
Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer GTV delineation with biparametric MRI and
Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
[TBL] [Abstract][Full Text] [Related]
16. [
Bettermann AS; Zamboglou C; Kiefer S; Jilg CA; Spohn S; Kranz-Rudolph J; Fassbender TF; Bronsert P; Nicolay NH; Gratzke C; Bock M; Ruf J; Benndorf M; Grosu AL
Radiother Oncol; 2019 Dec; 141():214-219. PubMed ID: 31431366
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual comparison between
Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
[TBL] [Abstract][Full Text] [Related]
18. Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer.
Liu LL; Zhu LL; Lu ZG; Sun JD; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2023 Jan; 23(1):1. PubMed ID: 36600283
[TBL] [Abstract][Full Text] [Related]
19. Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
Piroth MD; Pinkawa M; Holy R; Stoffels G; Demirel C; Attieh C; Kaiser HJ; Langen KJ; Eble MJ
Radiat Oncol; 2009 Nov; 4():57. PubMed ID: 19930657
[TBL] [Abstract][Full Text] [Related]
20. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
